Clinical Trial

ZNN Bactiguard Retrograde Femoral Nails PMCF Study

Recruiting
View on ClinicalTrials.gov →
Summary
Post-market clinical follow-up (PMCF) study to confirm the safety, performance, and clinical benefits of the intra-medullary retrograde femoral nail Zimmer Natural Nail (ZNN) Bactiguard (implants and instrumentation) when used for the temporary internal fixation and stabilization of femoral fractures.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-03-02; most recent amendment 2026-02-02.
Status change: Not Yet Recruiting → Recruiting 2024-05-31
Trial Details
NCT Number NCT05276674
Lead Sponsor Zimmer Biomet
Conditions Femoral Fracture
Enrollment 100 participants
Start Date 2023-10-23
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-03